Author:
Hong Yuling,Zhang Yunxing,Zhao Haibo,Chen Hailing,Yu Qing-Qing,Cui Hongxia
Abstract
Hepatocellular carcinoma (HCC) is the most frequent and deadly type of liver cancer. While the underlying molecular mechanisms are poorly understood, it is documented that lncRNAs may play key roles. Many HCC-associated lncRNAs have been linked to HBV and HCV infection, mediating gene expression, cell growth, development, and death. Studying the regulatory mechanisms and biological functions of HCC-related lncRNAs will assist our understanding of HCC pathogenesis as well as its diagnosis and management. Here, we address the potential of dysregulated lncRNAs in HCC as diagnostic and therapeutic biomarkers, and we evaluate the oncogenic or tumor-suppressive properties of these lncRNAs.
Subject
Cell Biology,Developmental Biology
Reference199 articles.
1. Detection of circulating tumor cells and their implications as a biomarker for diagnosis, prognostication, and therapeutic monitoring in hepatocellular carcinoma;Ahn;Hepatology,2021
2. EMT, MET, plasticity, and tumor metastasis;Bakir;Trends Cell Biol.,2020
3. Role of RNA modifications in cancer;Barbieri;Nat. Rev. Cancer,2020
4. Biogenesis and function of extracellular vesicles in cancer;Bebelman;Pharmacol. Ther.,2018
5. Group behavior and emergence of cancer drug resistance;Bhattacharya;Trends Cancer,2021
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献